PTPRC and metastatic malignant neoplasm in the lymph nodes: Moreover, more advanced lymph node metastasis status was associated with marginally and tendentiously higher CD3+ (N1 vs. N2: p = 0.0587, Figure 3B) and CD45+ (p = 0.1204, Figure 3C) cell counts, respectively.